Cadence Bank NA’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,037
| Closed | -$3.82M | – | 177 |
|
|
2022
Q2 | $3.82M | Sell |
7,037
-13
| -0.2% | -$7.16K | 1.24% | 20 |
|
|
2022
Q1 | $4.16M | Buy |
7,050
+18
| +0.3% | +$10.3K | 1.16% | 20 |
|
|
2021
Q4 | $4.69M | Sell |
7,032
-41
| -0.6% | -$25.6K | 1.28% | 18 |
|
|
2021
Q3 | $4.04M | Sell |
7,073
-49
| -0.7% | -$26.9K | 1.2% | 19 |
|
|
2021
Q2 | $3.59M | Buy |
7,122
+95
| +1% | +$44.8K | 1.07% | 23 |
|
|
2021
Q1 | $3.21M | Sell |
7,027
-155
| -2% | -$74K | 1.01% | 30 |
|
|
2020
Q4 | $3.35M | Buy |
7,182
+18
| +0.3% | +$8.44K | 1.18% | 25 |
|
|
2020
Q3 | $3.16M | Sell |
7,164
-80
| -1% | -$33.1K | 1.23% | 23 |
|
|
2020
Q2 | $2.63M | Buy |
7,244
+206
| +3% | +$69K | 1.11% | 26 |
|
|
2020
Q1 | $2M | Buy |
7,038
+868
| +14% | +$274K | 1.02% | 29 |
|
|
2019
Q4 | $2M | Buy |
6,170
+185
| +3% | +$56.1K | 0.74% | 40 |
|
|
2019
Q3 | $1.74M | Buy |
5,985
+141
| +2% | +$40.4K | 0.68% | 42 |
|
|
2019
Q2 | $1.72M | Buy |
5,844
+57
| +1% | +$15.7K | 0.67% | 46 |
|
|
2019
Q1 | $1.58M | Buy |
5,787
+62
| +1% | +$15.4K | 0.62% | 53 |
|
|
2018
Q4 | $1.28M | Sell |
5,725
-73
| -1% | -$17.1K | 0.58% | 54 |
|
|
2018
Q3 | $1.42M | Buy |
5,798
+386
| +7% | +$88.8K | 0.54% | 57 |
|
|
2018
Q2 | $1.12M | Buy |
5,412
+704
| +15% | +$149K | 0.46% | 66 |
|
|
2018
Q1 | $972K | Sell |
4,708
-34
| -0.7% | -$7.14K | 0.39% | 77 |
|
|
2017
Q4 | $900K | Sell |
4,742
-233
| -5% | -$44.6K | 0.33% | 84 |
|
|
2017
Q3 | $942K | Buy |
4,975
+64
| +1% | +$11.6K | 0.36% | 83 |
|
|
2017
Q2 | $856K | Buy |
4,911
+51
| +1% | +$8.57K | 0.39% | 70 |
|
|
2017
Q1 | $747K | Buy |
4,860
+119
| +3% | +$18.2K | 0.34% | 68 |
|
|
2016
Q4 | $669K | Buy |
4,741
+228
| +5% | +$33.6K | 0.31% | 70 |
|
|
2016
Q3 | $718K | Sell |
4,513
-27
| -0.6% | -$4.16K | 0.32% | 65 |
|
|
2016
Q2 | $671K | Sell |
4,540
-1
| -0% | -$148 | 0.33% | 66 |
|
|
2016
Q1 | $643K | Buy |
4,541
+296
| +7% | +$39.7K | 0.33% | 72 |
|
|
2015
Q4 | $602K | Buy |
4,245
+812
| +24% | +$108K | 0.32% | 71 |
|
|
2015
Q3 | $420K | Buy |
3,433
+616
| +22% | +$80.3K | 0.24% | 82 |
|
|
2015
Q2 | $365K | Buy |
2,817
+378
| +15% | +$49.3K | 0.24% | 75 |
|
|
2015
Q1 | $328K | Buy |
2,439
+100
| +4% | +$12.9K | 0.18% | 110 |
|
|
2014
Q4 | $293K | Buy |
2,339
+230
| +11% | +$28K | 0.16% | 124 |
|
|
2014
Q3 | $256K | Buy |
2,109
+140
| +7% | +$17K | 0.14% | 131 |
|
|
2014
Q2 | $232K | Buy |
+1,969
| New | +$232K | 0.12% | 142 |
|
|
2014
Q1 | – | Sell |
-2,338
| Closed | -$260K | – | 154 |
|
|
2013
Q4 | $260K | Buy |
+2,338
| New | +$232K | 0.14% | 126 |
|
Other funds holding TMO
Cadence Bank NA's TMO Position: Q3 2022 in Review
Cadence Bank NA sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 7,037 shares — an estimated $3.82M sold.
Cadence Bank NA first reported a position in TMO in Q4 2013 and held it in 34 quarters. The position peaked at $4.69M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- Cadence Bank NA reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
- Cadence Bank NA sold 7,037 Thermo Fisher Scientific shares in Q3 2022, an estimated $3.82M.
- Cadence Bank NA first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 34 quarters.
- Cadence Bank NA's Thermo Fisher Scientific position peaked at $4.69M in Q4 2021.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.